GALIANO GOLD REPORTS EXCEPTIONAL DRILL RESULTS AT ABORE, INCLUDING 23m @ 6.8 g/t Au AND 16.4m @ 5.3 g/t Au, WITH MULTIPLE ORE SHOOTS AND NEW HIGH-GRADE ZONE IDENTIFIED

Multiple new high-grade gold intercepts below the Mineral Resource at Abore highlight potential for Mineral Resource growth. VANCOUVER, BC, Aug. 20, 2025 /PRNewswire/ – Galiano Gold Inc. (“Galiano” or the “Company”) (TSX: GAU) (NYSE American: GAU) is pleased to announce an update on the Abore 2025 Phase 2 drilling program, currently underway at the Asanko Gold Mine […]

Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology. The […]

ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between August 10, 2023 and June 25, 2025. Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity, metabolic and liver diseases. […]

NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/S

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (NYSE: NVO) securities between May 7, 2025 and July 28, 2025. Novo Nordisk is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical […]

LINE STOCK: Robbins LLP Reminds LINE Stockholders of the Opportunity to Lead to the Class Action Lawsuit Against Lineage, Inc.

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with the Company’s 2024 initial public offering (“IPO”). Lineage is a Maryland REIT focused on temperature-controlled cold-manage […]

KASOWITZ LLP: ENVESTNET, INC. WAS FOUND TO HAVE ACTIVELY PARTICIPATED IN SPOLIATION AND NOW FACES A DELAWARE JURY TRIAL ON FINANCIALAPPS’ $100 MILLION TRADE SECRET MISAPPROPRIATION CLAIM

NEW YORK, Aug. 20, 2025 /PRNewswire/ — Six years into a $100 million lawsuit brought by Kasowitz LLP on behalf of fintech pioneer FinancialApps, LLC against defendants Envestnet, Inc. and Yodlee, Inc. for trade secret misappropriation, tortious interference, and unfair competition, a Special Master appointed by the Delaware District Court has recommended formal sanctions against both Envestnet (recently acquired […]

Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 2032 | DelveInsight

The demand for minimal residual disease testing is increasing mainly due to the higher prevalence of solid tumors and blood cancers like leukemia, multiple myeloma, and lymphoma. Continuous advances in molecular diagnostics have greatly improved MRD detection accuracy, and active product development and launches by leading companies are further boosting the market’s momentum. LAS VEGAS, […]